MKI67 and neuroendocrine carcinoma: The comparison of baseline clinical and imaging parameters between the two response groups revealed that NR had a significantly higher Ki-67 of the primary tumor (16.5% vs. 10.0%, p = 0.01) with three patients graded as neuroendocrine cancer (NEC) in the NR group (none in the R group).